Aesthetics

Latest News



Pizzazz for pills

National report - Drug companies can now start beautifying their pills with pigments like those that give cosmetics a pearly sheen, the Associated Press reports.

Kuala Lumpur, Malaysia - Muslims in Malaysia may have to learn to live with their wrinkles after the country's top Islamic xbody ruled against Botox (Allergan) injections.

Brits under the knife

London - By 2007, Britons will spend more on cosmetic surgery than they will on tea, according to the London Daily Telegraph.

Gene boosts melanoma risk

San Francisco - People with red hair, light skin or freckles are more likely to develop malignant melanoma, researchers say.

Melanoma, protein linked

Evanston, Ill. - Aggressive melanoma cells secrete Nodal, a protein critical to proper embryo formation, according to researchers at Northwestern University.

Skin test for Alzheimer's?

Morgantown, W.Va. -- A skin test that could allow detection of Alzheimer's disease in its earliest stages may become a reality.

Eckley M. Keach's article in the June 2006 issue of Dermatology Times ("Successful malpractice defense lies in body of evidence") provides tips for dermatologists to reduce the risk of malpractice liability from treating high-risk melanoma patients.

Cleveland – Dermatology Times has won a Gold Triangle Award from the American Academy of Dermatology for the article, "Bogus Botox sounds wake-up call" appearing in the February 2005 issue. The article, written by Senior Staff Correspondent John Jesitus, explored the proliferation of knock-off Botox and its untoward effects on patients. The article included dermatologists' opinions on the problem and how Allergan, Botox's manufacturer, was helping keep pure product in the market.

Stem cell research is among the "one or two paradigm-changing medical breakthroughs" that may occur in a lifetime, and it's vitally needed to bring hope to millions, says Ron Reagan, son of the late President Ronald Reagan. Mr. Reagan addressed the Friday morning plenary session at the American Academy of Dermatology's Academy '06, couching in impassioned and often stinging political commentary his plea for support for stem cell research.

While biologic drugs may not provide a first-line treatment for psoriasis, dermatologists are reaching for them somewhat more readily, an expert says.

San Francisco - Results from several studies performed with imiquimod 5 percent cream (Aldara, 3M Pharmaceuticals) suggest that the immune response modifier may have a role as a surgical adjuvant for improving local tumor control and/or to enhance scar appearance, says James M. Spencer, M.D., M.S., clinical professor of dermatology, Mt. Sinai School of Medicine, New York.